Facebook Linkedin RSS Twitter Youtube
Home 2024

Antiparkinson drugs

Parkinson’s Symptom, Resting Tremor, Relates to Dopamine in Unexpected Way
Featured

Parkinson’s Symptom, Resting Tremor, Relates to Dopamine in Unexpected Way

Alzheimer’s Disease Symptoms Lessened and Improved in Mice by Dopamine Treatment
Drug Discovery

Alzheimer’s Disease Symptoms Lessened and Improved in Mice by Dopamine Treatment

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial
Drug Discovery

Parkinson’s Disease Drug Slows ALS Progression in Clinical Trial

Regional Power: Japan’s Kyowa Kirin Builds on U.S. Growth
Cancer

Regional Power: Japan’s Kyowa Kirin Builds on U.S. Growth

FDA Extends PDUFA Date for Acorda’s Inbrija, 3 Days after Company Loses Ampyra Appeal
News

FDA Extends PDUFA Date for Acorda’s Inbrija, 3 Days after Company Loses Ampyra Appeal

FDA Refuses to File Acorda NDA for Inbrija
Industry News

FDA Refuses to File Acorda NDA for Inbrija

Adamas’ Gocovri Wins FDA Nod as First PD Treatment for Levodopa-Induced Dyskinesia
Drug Discovery

Adamas’ Gocovri Wins FDA Nod as First PD Treatment for Levodopa-Induced Dyskinesia

Mitsubishi Tanabe to Buy Parkinson’s Disease Drugs Firm NeuroDerm for $1.1B
Drug Discovery

Mitsubishi Tanabe to Buy Parkinson’s Disease Drugs Firm NeuroDerm for $1.1B

UCB to Help Neuropore Advance Parkinson’s Therapies in $480M Deal
Drug Discovery

UCB to Help Neuropore Advance Parkinson’s Therapies in $480M Deal

Lasker 2014 Awards Honor Five Scientists Excelling in Basic and Applied Clinical Research
News

Lasker 2014 Awards Honor Five Scientists Excelling in Basic and Applied Clinical Research

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.